南美洲 ECMO 市场预测至 2028 年 - COVID-19 影响和区域分析 - 按模式（静脉动脉 ECMO、静脉静脉 ECMO 和动静脉 ECMO）、应用（呼吸和心脏病）和年龄组（成人、儿科和新生儿）
No. of Pages: 112 | Report Code: BMIRE00027974 | Category: Life Sciences
No. of Pages: 112 | Report Code: BMIRE00027974 | Category: Life Sciences
肺移植是一种挽救生命的方法为患有慢性阻塞性肺病、特发性肺纤维化 (IPF) 和囊性纤维化等终末期肺部疾病的患者提供治疗选择，以改善生活质量。 ECMO 是一种多功能工具，适用于肺移植的所有阶段，例如术前、术中和术后。它充当接受肺移植的患者的桥梁。因此，在肺移植过程中采用 ECMO 来治疗危及生命的肺病患者的情况正在迅速增长。原发性移植物功能障碍（PGD）是肺移植后死亡的主要原因。因此，ECMO 倒数第二次用于治疗肺移植后的 PGD。因此，治疗PGD患者对ECMO设备的需求不断增长。
南美洲 ECMO 市场分为巴西、阿根廷和南美洲其他地区。巴西在2022年占据市场主导地位。根据世界心脏联合会的数据，心血管疾病等非传染性疾病占巴西总死亡人数的74%。根据全球负担研究（GBD）和巴西统一卫生系统的数据，心血管疾病是2019年巴西的首要死因。由于巴西人口老龄化加剧，心血管疾病的患病率逐年上升。 GBD的数据显示，2019年，缺血性心脏病（IHD）病例数达到400万例。此外，约有171,246人因IHD死亡，占2019年巴西心血管死亡的43%，占总死亡人数的12%。因此，巴西不断增长的心血管疾病病例正在推动该国 ECMO 市场的增长。
南美洲 ECMO 市场根据模式、应用、年龄组和国家进行细分。
根据模式，南美ECMO市场分为静脉动脉ECMO、静脉静脉ECMO和动静脉ECMO。静脉动脉ECMO细分市场在2022年占据最大的市场份额。
根据应用，南美ECMO市场分为呼吸系统和心脏病学。到2022年，呼吸领域将占据更大的市场份额。
根据年龄组，南美ECMO市场分为成人、儿科和新生儿。 2022 年，成人细分市场占据最大市场份额。
按国家划分，南美 ECMO 市场分为巴西、阿根廷和南美洲其他地区。我们的区域分析表明，巴西将在 2022 年占据市场主导地位。 Biomedica、Fresenius Medical Care AG 和Co KGaA、Getinge AB、LivaNova Plc、Medtronic Plc、MicroPort Scientific Corporation、Nipro Medical Corporation 和 Terumo Group 是南美 ECMO 市场的领先公司。
Strategic insights for South America ECMO involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 53.00 Million |
| Market Size by 2028 | US$ 60.58 Million |
| Global CAGR (2022 - 2028) | 2.3% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 治疗方式
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South America ECMO refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South America ECMO Market is valued at US$ 53.00 Million in 2022, it is projected to reach US$ 60.58 Million by 2028.
As per our report South America ECMO Market, the market size is valued at US$ 53.00 Million in 2022, projecting it to reach US$ 60.58 Million by 2028. This translates to a CAGR of approximately 2.3% during the forecast period.
The South America ECMO Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America ECMO Market report:
The South America ECMO Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South America ECMO Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South America ECMO Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South America ECMO Market
